The Gillett Health Podcast cover image

Semaglutide VS Tirzepatide | The Gillett Health Podcast #76

The Gillett Health Podcast

00:00

Intro

The chapter includes ads for Nuculus Network seeking participants with moderate to severe kidney impairment for studies offering compensation from $2,000 to $7,000, and Baker's Pharmacy showcasing their convenient care services such as evening hours, insurance acceptance, and online prescription management.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app